Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D0U7GL | ||||
| Former ID | DNC003359 | ||||
| Drug Name | N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [551393] | ||
| Formula | C14H13FN2O3S | ||||
| Canonical SMILES | C1=CC=C(C(=C1)CNC(=O)C2=CC=C(C=C2)S(=O)(=O)N)F | ||||
| InChI | 1S/C14H13FN2O3S/c15-13-4-2-1-3-11(13)9-17-14(18)10-5-7-12(8-6-10)21(16,19)20/h1-8H,9H2,(H,17,18)(H2,16,19,20) | ||||
| InChIKey | ULYMHSXFSKOHGH-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Carbonic anhydrase II | Target Info | Inhibitor | [551393] | |
| NetPath Pathway | IL4 Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
